Overview

Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without Cirrhosis

Status:
Completed

Trial end date:
2020-05-18

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to evaluate the safety and tolerability of cilofexor in adults with primary sclerosing cholangitis (PSC).

Phase:

Phase 2

Details

Lead Sponsor:

Gilead Sciences